Anurag Bajpayee, Founder and CEO, Gradiant
Panel moderator: Marcus Dahllof, Program Director, MIT Startup Exchange Panelists: Caleb Harper, Director, OpenAg, MIT Media Lab Dilip Sundaram, President, Corporate, Mahindra Group - Americas Jan Schnorr, CEO, C2Sense Alan Kriz, Strategic Alliance Manager, Crop Science, Bayer Tejal Mody, Managing Director, Rabobank
James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.
Sertac Karaman, Cofounder, Optimus Ride
Sandro Catanzaro Co-Founder DataXu
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Interpretable AI co-founders, Jack Dunn and Daisy Zhuo
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Salvatore Mascia, Founder and CEO, CONTINUUS Pharmaceuticals